Open Orphan plc (LON:ORPH) Chief Executive Officer Yamin ‘Mo’ Khan talks through the FY2021 Financial Results and the outlook for 2022.
Mo covers topics:
Key Strategic Value Adding Initiatives,
Summary Financial Highlights,
Attractive Market Dynamics,
Growth of Vaccines & Anti-Virals,
Open Orphan (LON ORPH) is the world leader in testing infectious & respiratory disease products using human challenge studies addressing the growing infectious disease market.